Key facts
- This page summarizes Keith Valentine's Form 4 filing for SeaSpine Holdings Corp.
- 10 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 09 Jan 2023, 18:16.
Keith Valentine - 05 Jan 2023 Form 4 Insider Report for SeaSpine Holdings Corp
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- N/A
- Reported as of
- 05 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jan 2023, 18:16:12 UTC
- Prior SEC filing
- 03 Jan 2023
- Next SEC filing
- 01 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Benny, Attorney-in-Fact for Keith C. Valentine
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Keith Valentine filed Form 4 for SeaSpine Holdings Corp on 09 Jan 2023.
Change
- Previous filing in this sequence was filed on 03 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SPNE
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -333,797
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SPNE
transaction
Derivative
Restricted Stock Units
Disposed to Issuer
- Transaction value
- Shares
- -52,392
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 52,392
- Exercise price
- Footnotes
- F2, F3, F4
SPNE
transaction
Derivative
Restricted Stock Units
Disposed to Issuer
- Transaction value
- Shares
- -236,779
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 236,779
- Exercise price
- Footnotes
- F2, F5, F6
SPNE
transaction
Derivative
Employee Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- Shares
- -325,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 325,000
- Exercise price
- $15.68
- Footnotes
- F7, F8
SPNE
transaction
Derivative
Employee Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- Shares
- -149,074
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 149,074
- Exercise price
- $14.19
- Footnotes
- F9, F10
SPNE
transaction
Derivative
Employee Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- Shares
- -77,881
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 77,881
- Exercise price
- $18.24
- Footnotes
- F11, F12
SPNE
transaction
Derivative
Employee Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- Shares
- -121,830
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 121,830
- Exercise price
- $12.01
- Footnotes
- F13, F14
SPNE
transaction
Derivative
Employee Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- Shares
- -8,871
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,871
- Exercise price
- $9.93
- Footnotes
- F15, F16
SPNE
transaction
Derivative
Employee Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- Shares
- -261,699
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 261,699
- Exercise price
- $16.86
- Footnotes
- F17, F18
SPNE
transaction
Derivative
Employee Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- Shares
- -31,866
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,866
- Exercise price
- $15.00
- Footnotes
- F19, F20
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Keith Valentine is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 20 footnotes
Footnote F1
Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 138,959 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.
Footnote F3
The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
Footnote F4
These restricted stock units were assumed by Orthofix in the merger and replaced by 21,810 Orthofix restricted stock units.
Footnote F5
The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
Footnote F6
These restricted stock units were assumed by Orthofix in the merger and replaced by 98,571 Orthofix restricted stock units.
Footnote F7
The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Footnote F8
This option was assumed by Orthofix in the merger and replaced with an option to purchase 135,297 shares of Orthofix at a price of $37.67 per share.
Footnote F9
The option vests as to 6.25% on June 1, 2016, 6.25% on June 30, 2016 and the remaining 87.5% in fourteen equal quarterly installments thereafter.
Footnote F10
This option was assumed by Orthofix in the merger and replaced with an option to purchase 62,059 shares of Orthofix at a price of $34.09 per share.
Footnote F11
The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Footnote F12
This option was assumed by Orthofix in the merger and replaced with an option to purchase 32,421 shares of Orthofix at a price of $43.82 per share.
Footnote F13
The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Footnote F14
This option was assumed by Orthofix in the merger and replaced with an option to purchase 50,717 shares of Orthofix at a price of $28.85 per share.
Footnote F15
The option fully vested and became exercisable on June 21, 2020.
Footnote F16
This option was assumed by Orthofix in the merger and replaced with an option to purchase 3,692 shares of Orthofix at a price of $23.86 per share.
Footnote F17
The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Footnote F18
This option was assumed by Orthofix in the merger and replaced with an option to purchase 108,945 shares of Orthofix at a price of $40.50 per share.
Footnote F19
The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Footnote F20
This option was assumed by Orthofix in the merger and replaced with an option to purchase 13,265 shares of Orthofix at a price of $36.04 per share.